118 related articles for article (PubMed ID: 38643540)
1. A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection.
Liao J; Zhang X; Zeng X; Zhao Z; Sun T; Xia Z; Jing H; Yuan Y; Chen Z; Gou Q; Zhao L; Zhang W; Zou Q; Zhang J
Biomed Pharmacother; 2024 May; 174():116611. PubMed ID: 38643540
[TBL] [Abstract][Full Text] [Related]
2. Co-immunization with DNA vaccines encoding yidR and IL-17 augments host immune response against
Lv Z; Zhang X; Zhao K; Du L; Wang X; Chu Y; Huang T
Virulence; 2024 Dec; 15(1):2345019. PubMed ID: 38656137
[No Abstract] [Full Text] [Related]
3. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
Hussein KE; Bahey-El-Din M; Sheweita SA
Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
[TBL] [Abstract][Full Text] [Related]
4. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
[TBL] [Abstract][Full Text] [Related]
5. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against
Zhang BZ; Hu D; Dou Y; Xiong L; Wang X; Hu J; Xing SZ; Li W; Cai JP; Jin M; Zhang M; Lin Q; Li M; Yuen KY; Huang JD
Front Immunol; 2021; 12():730116. PubMed ID: 34745099
[No Abstract] [Full Text] [Related]
6. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.
Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M
Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.
Kurupati P; Ramachandran NP; Poh CL
Clin Vaccine Immunol; 2011 Jan; 18(1):82-8. PubMed ID: 21048001
[TBL] [Abstract][Full Text] [Related]
8. A novel chimeric vaccine containing multiple epitopes for simulating robust immune activation against Klebsiella pneumoniae.
Hakimian M; Doosti A; Sharifzadeh A
BMC Immunol; 2024 May; 25(1):27. PubMed ID: 38706005
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.
Lee WH; Choi HI; Hong SW; Kim KS; Gho YS; Jeon SG
Exp Mol Med; 2015 Sep; 47(9):e183. PubMed ID: 26358222
[TBL] [Abstract][Full Text] [Related]
10. Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice.
Kumar A; Harjai K; Chhibber S
Microb Pathog; 2020 Jul; 144():104161. PubMed ID: 32194179
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of the immunogenicity of a monopreparation of Klebsiella pneumoniae antigen complex and its association with Staphylococcus, Proteus and Escherichia coli antigens].
Egorova NB; Mansurova NL; Kurbatova EA; Efremova VN; Kreĭnin LS
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):35-8. PubMed ID: 6367319
[TBL] [Abstract][Full Text] [Related]
12. A promising bioconjugate vaccine against hypervirulent
Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
[TBL] [Abstract][Full Text] [Related]
13. Development of Drug-Resistant
Li W; Hu Y; Zhang Q; Hua L; Yang Z; Ren Z; Zheng X; Huang W; Ma Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32703-32715. PubMed ID: 34251169
[TBL] [Abstract][Full Text] [Related]
14. Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae.
Jain RR; Mehta MR; Bannalikar AR; Menon MD
Biologicals; 2015 May; 43(3):195-201. PubMed ID: 25737397
[TBL] [Abstract][Full Text] [Related]
15. Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.
Peng Z; Wu J; Wang K; Li X; Sun P; Zhang L; Huang J; Liu Y; Hua X; Yu Y; Pan C; Wang H; Zhu L
Adv Sci (Weinh); 2021 Jul; 8(14):e2100549. PubMed ID: 34032027
[TBL] [Abstract][Full Text] [Related]
16. The Long Pentraxin PTX3 Controls
Asgari F; Supino D; Parente R; Polentarutti N; Stravalaci M; Porte R; Pasqualini F; Barbagallo M; Perucchini C; Recordati C; Magrini E; Mariancini A; Riva F; Giordano A; Davoudian S; Roger T; Veer CV; Jaillon S; Mantovani A; Doni A; Garlanda C
Front Immunol; 2021; 12():666198. PubMed ID: 34093560
[No Abstract] [Full Text] [Related]
17. [Protective activity of a cell-free Klebsiella vaccine in infection in mice caused by Streptococcus pneumoniae serotypes].
Kurbatova EA; Egorova NB; Krasnoproshina LI; Rodionychev EA; Mansurova NL
Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):60-5. PubMed ID: 3887815
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae.
Chathley UC; Sharma S; Chhibber S
Folia Microbiol (Praha); 1996; 41(4):373-6. PubMed ID: 9131794
[TBL] [Abstract][Full Text] [Related]
19. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
[TBL] [Abstract][Full Text] [Related]
20. Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.
Gu H; Zeng X; Peng L; Xiang C; Zhou Y; Zhang X; Zhang J; Wang N; Guo G; Li Y; Liu K; Gu J; Zeng H; Zhuang Y; Li H; Zhang J; Zhang W; Zou Q; Shi Y
Elife; 2021 Sep; 10():. PubMed ID: 34544549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
